Canada’s Drug Agency Seeks Nominations for Expert and Advisory Committee Members
Read more about Canada’s Drug Agency Seeks Nominations for Expert and Advisory Committee Members
Canada’s Drug Agency Announces a New Round of Funding to Enhance Rare Disease Registries
Read more about Canada’s Drug Agency Announces a New Round of Funding to Enhance Rare Disease Registries
New Watch List Spotlights Advances and Issues in Artificial Intelligence Use in Canadian Health Care
Read more about New Watch List Spotlights Advances and Issues in Artificial Intelligence Use in Canadian Health Care
Featured Reports
Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all
We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.
A National Capital Region’s top employer
We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2025.
Latest News
New Watch List Spotlights Advances and Issues in Artificial Intelligence Use in Canadian Health Care
Upcoming Events
Information Session: 2025-2026 Funding Opportunity for Rare Disease Registry Improvement
Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.